Urology Times ® The Leading News Source for Urologists Vol. 32, No. 10

First Page		Document Content
Date: 2015-02-13 15:50:26 Chronic prostatitis/chronic pelvic pain syndrome Interstitial cystitis Pelvic pain Prostatitis Prostate cancer Prostate massage Finasteride Combination therapy Chronic bacterial prostatitis Health Medicine Syndromes		Urology Times ® The Leading News Source for Urologists Vol. 32, No. 10 Add to Reading List Source URL: www.prostatitis.org Download Document from Source Website File Size: 52,07 KB Share Document on Facebook

$6-Day Intensive Treatment Protocol for Refractory Chronic Prostatitis/Chronic Pelvic Pain Syndrome Using Myofascial Release and Paradoxical Relaxation Training$	6-Day Intensive Treatment Protocol for Refractory Chronic Prostatitis/Chronic Pelvic Pain Syndrome Using Myofascial Release and Paradoxical Relaxation Training DocID: 1d69x - View Document
	http://www.reuters.com/articlePrint?articleId=US180628%2B24-Jun DocID: 19NC0 - View Document
	TARIS® Secures $12.5 Million in Additional Financing; Initiates Phase 2 Trial of Lead Product Candidate Lexington, MA – April 2nd, 2013 – TARIS Biomedical®, a specialty pharmaceutical company developing innovative, DocID: 19L9P - View Document
	TARIS SUCCESSFULLY COMPLETES PHASE 1 STUDY -- First Human Trial Enables Development for Several Indications -Lexington, MA – December 2, 2009 – TARIS Biomedical, a specialty pharmaceutical company pioneering the fiel DocID: 19F0k - View Document
	TARIS® Announces Dosing of First Patient in Second Phase 2 Clinical Study of LiRIS® in Interstitial Cystitis Lexington, MA – April 2nd, 2013 – TARIS Biomedical®, a specialty pharmaceutical company developing innov DocID: 19AVH - View Document